Clinical Trial: Low-dose UVA1 Radiation in Cutaneous Lupus Patients

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Low-dose UVA1 Radiation in Cutaneous Lupus Patients

Brief Summary: The investigators are conducting an open-label clinical trial determining the effects of UVA1 phototherapy on cutaneous lupus (CLE) patients. Past research on systemic lupus (SLE) subjects indicates that this treatment is likely to be effective in treating cutaneous lupus with few side effects. The fact that most CLE patients are seen at dermatology clinics also increases the usefulness of this study because there is a large probability that phototherapy treatment will be accessible for many of the patients that stand to benefit from it.